MediPharm Labs Corp. (MEDIF)
OTCMKTS
· Delayed Price · Currency is USD
0.0609
0.00 (0.00%)
Apr 25, 2025, 1:29 PM EDT
MediPharm Labs Revenue
In the year 2024, MediPharm Labs had annual revenue of 41.96M CAD with 26.92% growth. MediPharm Labs had revenue of 12.04M in the quarter ending December 31, 2024, with 31.88% growth.
Revenue
41.96M CAD
Revenue Growth
+26.92%
P/S Ratio
0.92
Revenue / Employee
260.63K CAD
Employees
161
Market Cap
26.96M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |
MediPharm Labs News
- 27 days ago - MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results - PRNewsWire
- 4 weeks ago - MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial Results - PRNewsWire
- 2 months ago - MediPharm Labs Announces Termination of the Proposed Sale of Napanee Facility to Kensana Health - PRNewsWire
- 3 months ago - MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health - PRNewsWire
- 3 months ago - MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil - PRNewsWire
- 4 months ago - MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M - PRNewsWire
- 5 months ago - MediPharm Labs Reports Third Quarter Results - PRNewsWire
- 5 months ago - MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results - PRNewsWire